Unknown

Dataset Information

The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone.


ABSTRACT:

Background

Simplistic two-dimensional (2D) in vitro assays have long been the standard for studying the metastatic abilities of cancer cells. However, tri-dimensional (3D) organotypic models provide a more complex environment, closer to that seen in patients, and thereby provide a more accurate representation of their true capabilities. Our laboratory has previously shown that the antiprogestin and antiglucocorticoid mifepristone can reduce the growth, adhesion, migration, and invasion of various aggressive cancer cells assessed using 2D assays. In this study, we characterize the metastatic capabilities of high-grade serous ovarian cancer cells generated along disease progression, in both 2D and 3D assays, and the ability of cytostatic doses of mifepristone to inhibit them.

Meth

SUBMITTER: Ritch SJ 

PROVIDER: S-EPMC9733158 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature